InflaRx NV sell djassam
Start price
21.12.23
/
50%
€1.35
Target price
21.12.24
-
Performance (%)
-17.56%
Price
13:05
€1.11
Summary
This prediction is currently active. The prediction for InflaRx NV shows a convincing performance of -17.56%. This prediction currently runs until 21.12.24. The prediction end date can be changed by djassam at any time. djassam has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
InflaRx NV | -13.704% | -13.704% |
iShares Core DAX® | 4.094% | 4.888% |
iShares Nasdaq 100 | 1.424% | -0.445% |
iShares Nikkei 225® | -1.572% | -4.911% |
iShares S&P 500 | 1.822% | 0.776% |
Comments by djassam for this prediction
In the thread InflaRx NV diskutieren
The comment has been deleted
InflaRx's commitment to innovative therapies in immunology, particularly in addressing inflammatory diseases, is commendable. Their focus on cutting-edge research, especially with IFX-1's clinical trials, showcases their dedication to meeting unmet medical needs - pokedoku